170 related articles for article (PubMed ID: 29139136)
1. Tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles to pigs: Combined antibacterial activities and pharmacokinetics.
Ling Z; Yonghong L; Junfeng L; Li Z; Xianqiang L
J Vet Pharmacol Ther; 2018 Apr; 41(2):307-313. PubMed ID: 29139136
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and pharmacokinetics of tilmicosin- and florfenicol-loaded hydrogenated castor oil-solid lipid nanoparticles.
Ling Z; Yonghong L; Changqing S; Junfeng L; Li Z; Chunyu J; Xianqiang L
J Vet Pharmacol Ther; 2017 Jun; 40(3):293-303. PubMed ID: 27687707
[TBL] [Abstract][Full Text] [Related]
3. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and pharmacokinetics of doxycycline hydrochloride and florfenicol polyvinylpyrroliddone microparticle entrapped with hydroxypropyl-β-cyclodextrin inclusion complexes suspension.
Li X; Xie S; Pan Y; Qu W; Tao Y; Chen D; Huang L; Liu Z; Wang Y; Yuan Z
Colloids Surf B Biointerfaces; 2016 May; 141():634-642. PubMed ID: 26918512
[TBL] [Abstract][Full Text] [Related]
5. Tilmicosin enteric granules and premix to pigs: Antimicrobial susceptibility testing and comparative pharmacokinetics.
Xiong J; Zhu Q; Zhao Y; Yang S; Cao J; Qiu Y
J Vet Pharmacol Ther; 2019 May; 42(3):336-345. PubMed ID: 30801755
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tilmicosin in healthy pigs and in pigs experimentally infected with
Zhang L; Zhao L; Liu Y; Liu J; Li X
J Vet Sci; 2017 Dec; 18(4):431-437. PubMed ID: 28385011
[TBL] [Abstract][Full Text] [Related]
8. Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies.
Han C; Qi CM; Zhao BK; Cao J; Xie SY; Wang SL; Zhou WZ
J Vet Pharmacol Ther; 2009 Apr; 32(2):116-23. PubMed ID: 19290940
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antibacterial activity of tilmicosin-SLN against
Zhu L; Cao X; Xu Q; Su J; Li X; Zhou W
Int J Nanomedicine; 2018; 13():4747-4755. PubMed ID: 30147316
[TBL] [Abstract][Full Text] [Related]
10. Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.
Xie S; Wang F; Wang Y; Zhu L; Dong Z; Wang X; Li X; Zhou W
Part Fibre Toxicol; 2011 Nov; 8():33. PubMed ID: 22098626
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pharmacokinetics of tilmicosin in healthy pigs and pigs experimentally infected with
Xiong J; Zhu Q; Yang S; Zhao Y; Cui L; Zhuang F; Qiu Y; Cao J
N Z Vet J; 2019 Sep; 67(5):257-263. PubMed ID: 31208293
[No Abstract] [Full Text] [Related]
12. Enhancement of antibacterial activity of tilmicosin against Staphylococcus aureus by solid lipid nanoparticles in vitro and in vivo.
Wang XF; Zhang SL; Zhu LY; Xie SY; Dong Z; Wang Y; Zhou WZ
Vet J; 2012 Jan; 191(1):115-20. PubMed ID: 21900026
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolates from clinical outbreaks of porcine respiratory diseases.
Kucerova Z; Hradecka H; Nechvatalova K; Nedbalcova K
Vet Microbiol; 2011 May; 150(1-2):203-6. PubMed ID: 21316872
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.
Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of tylosin or florfenicol after a single intramuscular administration at two different doses of tylosin-florfenicol combination in pigs.
Kim MH; Gebru E; Chang ZQ; Choi JY; Hwang MH; Kang EH; Lim JH; Yun HI; Park SC
J Vet Med Sci; 2008 Jan; 70(1):99-102. PubMed ID: 18250580
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibacterial activity of florfenicol against Actinobacillus pleuropneumoniae.
Ueda Y; Suenaga I
J Vet Med Sci; 1995 Apr; 57(2):363-4. PubMed ID: 7492665
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of four antimicrobials against Riemerella anatipestifer isolates: a comparison of minimum inhibitory concentrations and mutant prevention concentrations for ceftiofur, cefquinome, florfenicol, and tilmicosin.
Li Y; Zhang Y; Ding H; Mei X; Liu W; Zeng J; Zeng Z
BMC Vet Res; 2016 Nov; 12(1):250. PubMed ID: 27829415
[TBL] [Abstract][Full Text] [Related]
18. Integration of pharmacokinetic-pharmacodynamic for dose optimization of doxycycline against Haemophilus parasuis in pigs.
Zhang L; Li Y; Wang Y; Sajid A; Ahmed S; Li X
J Vet Pharmacol Ther; 2018 Oct; 41(5):706-718. PubMed ID: 29696661
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tilmicosin phosphate (Pulmotil premix) in feed for the treatment of a clinical outbreak of Actinobacillus pleuropneumoniae infection in growing-finishing pigs.
Hoflack G; Maes D; Mateusen B; Verdonck M; de Kruif A
J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):655-64. PubMed ID: 11765801
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of enteric-coated tilmicosin granules in pigs artificially infected with Actinobacillus pleuropneumoniae serotype 2.
Dong Z; Zhou XZ; Sun JC; Meng XB; Li HS; Cheng FS; Wei XJ; Li B; Wang WW; Zhang JY
Vet Med Sci; 2020 Feb; 6(1):105-113. PubMed ID: 31589010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
